|
Associate Director, Quality Technology Delivery
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Associate Director, Procurement Operations
|
Cambridge, MA, US, 02142
|
Jun 6, 2026
|
Full-Time
|
|
|
Associate Director, People Operations & Transformation
|
Cambridge, MA, US, 02142
|
Jun 6, 2026
|
Full-Time
|
|
|
Associate Director, Observational Data Methods and Analytics
|
Cambridge, MA, US, 02142
|
Jun 7, 2026
|
Full-Time
|
|
|
Associate Director, Medical Training
|
Zug, CH, 6300
|
Jun 10, 2026
|
Full-Time
|
|
|
Associate Director, Marketing Technology
|
Cambridge, MA, US, 02142
|
May 31, 2026
|
Full-Time
|
|
|
Associate Director, Insights and Analytics
|
Cambridge, MA, US, 02142
|
May 23, 2026
|
Full-Time
|
|
|
Associate Director, GxP Audits and Inspection Excellence
|
Cambridge, MA, US, 02142
|
Jun 5, 2026
|
Full-Time
|
|
|
Associate Director, Global Labeling
|
Cambridge, MA, US, 02142
|
Jun 4, 2026
|
Full-Time
|
|
|
Associate Director, Field Systems and Technology
|
Cambridge, MA, US, 02142
|
May 23, 2026
|
Full-Time
|
|
|
Associate Director, Field Business Lead - Rare Diseases
|
CA
|
Jun 12, 2026
|
Full-Time
|
|
|
Associate Director, Epidemiology
|
Cambridge, MA, US, 02142
|
May 18, 2026
|
Full-Time
|
|
|
Associate Director, Early Development Quality Lead, R&D QA
|
Cambridge, MA, US, 02142
|
Jun 5, 2026
|
Full-Time
|
|
|
Associate Director, Data Stewardship
|
Cambridge, MA, US, 02142
|
Jun 2, 2026
|
Full-Time
|
|
|
Associate Director, CMC Technology Delivery
|
Cambridge, MA, US, 02142
|
Jun 4, 2026
|
Full-Time
|
|
|
Associate Director, Clinical Science
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Associate Director, Clinical Quality and Continuous Improvement
|
Cambridge, MA, US, 02142
|
May 28, 2026
|
Full-Time
|
|
|
Associate Director, Clinical Portfolio Technology
|
Cambridge, MA, US, 02142
|
May 28, 2026
|
Full-Time
|
|
|
Associate Director, Clinical Pharmacology
|
Cambridge, MA, US, 02142
|
May 18, 2026
|
Full-Time
|
|
|
Associate Director, Clinical Pharmacology
|
NL
|
May 31, 2026
|
Full-Time
|
|